Shuchismita Satpathy, MD

Medical Oncology
English
Adults 18-64, Seniors 65+

Meet Shuchismita Satpathy, MD

A Physician-Scientist Bringing Research-Driven Cancer Care to Santa Fe

A cancer diagnosis changes everything in an instant — and you deserve an oncologist who understands both the science behind your treatment and the human reality of living through it. Dr. Shuchismita Roy Satpathy is a medical oncologist and physician-scientist at CHRISTUS Health in Santa Fe, New Mexico. Having grown up in a medically underserved community with high cancer incidence, Dr. Satpathy brings a personal understanding of what it means when access to expert oncology care is not a given — and she brings that awareness to every patient she sees in Santa Fe.

 

Career at a Glance

  • Physician-scientist with both an M.D. and a Ph.D. in Immunology — training that allows her to connect laboratory science directly to clinical treatment decisions
  • Published researcher with over 350 citations across peer-reviewed publications, 14 in journals including Nature Communications, Journal of Clinical Oncology, Blood, Cancer Research, and Cancer Immunology Research
  • U.S. patent holder for compositions and methods for use in treating silicosis and lung cancer
  • Multilingual: English, Bengali, Hindi, and Urdu 
  • Member of the American Society for Clinical Oncology, American Society of Hematology, American Association for Cancer Research, and American Association for the Advancement of Science.

 

Clinical Role

Dr. Satpathy practices at CHRISTUS St. Vincent Regional Cancer Center in Santa Fe — the region's only nationally accredited cancer program. Her dual training in clinical oncology and laboratory immunology gives her a perspective that few oncologists bring to community-based cancer care: the ability to evaluate not only standard treatment options but also emerging therapies and clinical trials grounded in the molecular biology of each patient's disease. Her research background in tumor immunology and breast cancer biology directly informs how she thinks about treatment for the patients in front of her.

She provides specialized care for conditions such as:

  • Breast cancer — including triple-negative breast cancer and hormone receptor-positive disease
  • Head and neck cancers — including squamous cell carcinoma treated with concurrent chemoradiation
  • Melanoma
  • Lung cancer
  • Gastrointestinal cancers — including pancreatic cancer
  • Genitourinary cancers
  • Management of immunotherapy-related toxicities

 

What You Can Expect from Care with Dr. Satpathy

Dr. Satpathy's approach to cancer care is shaped by years of scientific training and a personal connection to communities where access to expert oncology has historically been limited. She works to bring precision medicine and clinical trial access to her patients to achieve better outcomes — translating complex molecular data into treatment plans that are clear, specific, and built around each person's diagnosis. For patients navigating the uncertainty of a cancer diagnosis, her goal is not just to treat the disease but to make sure you understand your options and feel supported in every decision.

You can expect:

  • A thorough explanation of your diagnosis, including the biology driving your cancer and why a specific treatment is recommended
  • An oncologist who evaluates whether clinical trials or emerging therapies may be appropriate for your situation — not just standard protocols
  • Treatment plans informed by the latest research in tumor immunology, precision medicine, and targeted therapies
  • Coordination with a full cancer care team — including radiation oncologists, surgical oncologists, nurses, social workers, and dietitians — at a nationally accredited cancer center

Locations


Hospital Affiliations

CHRISTUS St. Vincent Regional Medical Center


Education & Certifications

Fellowship: Zucker School Of Medicine At Hofstra/Northwell

Residency: Harbor-UCLA Medical Center

Medical Education: University of Louisville School of Medicine

Graduate School: National Institute of Immunology